MedPath

Establishment of a Northeast Asian cohort of non-alcoholic fatty liver patients based on liver biopsy

Not Applicable
Active, not recruiting
Conditions
Diseases of the digestive system
Registration Number
KCT0008787
Lead Sponsor
Hanyang University Seoul Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Active, not recruiting
Sex
All
Target Recruitment
2500
Inclusion Criteria

Patients with non-alcoholic fatty liver disease whose fatty liver and liver fibrosis were clearly evaluated by performing a biopsy will be included between January 1, 1995 and March 31, 2023.

Exclusion Criteria

- Patients under the age of 19.
- Patients with other liver disease (viral hepatitis, liver cancer, autoimmune liver disease, primary biliary cirrhosis, Wilson's disease, drug-induced hepatitis or liver damage).
- Patients with malignant tumors.

Study & Design

Study Type
Observational Study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath